DexCom, Inc. provided earnings guidance for the year 2022. For the year 2022, the company expects revenue of approximately $2.88 billion to $2.91 billion (18-19% reported growth).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.4 USD | -0.42% | +3.39% | +5.86% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.86% | 52.46B | |
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B | |
-1.25% | 24.94B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- DexCom, Inc. Provides Earnings Guidance for the Year 2022